Rehmann Capital Advisory Group increased its position in shares of Metlife Inc (NYSE:MET) by 46.6% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 27,150 shares of the financial services provider’s stock after purchasing an additional 8,634 shares during the period. Rehmann Capital Advisory Group’s holdings in Metlife were worth $1,184,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in MET. Cambridge Investment Research Advisors Inc. increased its position in Metlife by 12.8% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 81,370 shares of the financial services provider’s stock worth $3,734,000 after purchasing an additional 9,239 shares during the last quarter. Cetera Advisor Networks LLC increased its position in shares of Metlife by 43.6% during the first quarter. Cetera Advisor Networks LLC now owns 7,356 shares of the financial services provider’s stock valued at $341,000 after acquiring an additional 2,233 shares during the last quarter. Glen Harbor Capital Management LLC increased its position in shares of Metlife by 103.1% during the first quarter. Glen Harbor Capital Management LLC now owns 48,804 shares of the financial services provider’s stock valued at $2,240,000 after acquiring an additional 24,780 shares during the last quarter. Federated Investors Inc. PA increased its position in shares of Metlife by 55.4% during the first quarter. Federated Investors Inc. PA now owns 67,936 shares of the financial services provider’s stock valued at $3,117,000 after acquiring an additional 24,228 shares during the last quarter. Finally, Candriam Luxembourg S.C.A. increased its position in shares of Metlife by 108.7% during the first quarter. Candriam Luxembourg S.C.A. now owns 185,069 shares of the financial services provider’s stock valued at $8,493,000 after acquiring an additional 96,396 shares during the last quarter. Hedge funds and other institutional investors own 77.47% of the company’s stock.

A number of equities research analysts have weighed in on MET shares. Zacks Investment Research upgraded shares of Metlife from a “hold” rating to a “buy” rating and set a $54.00 price target for the company in a research report on Friday, October 5th. Credit Suisse Group dropped their price target on shares of Metlife from $67.00 to $63.00 and set an “outperform” rating for the company in a research report on Friday, August 17th. Morgan Stanley dropped their price target on shares of Metlife from $53.00 to $52.00 and set an “equal weight” rating for the company in a research report on Wednesday, July 11th. Barclays lowered their price objective on shares of Metlife from $60.00 to $57.00 and set an “overweight” rating for the company in a research note on Monday, July 9th. Finally, Wells Fargo & Co reissued a “buy” rating and issued a $60.00 price objective on shares of Metlife in a research note on Thursday, September 27th. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and seven have assigned a buy rating to the company’s stock. Metlife has a consensus rating of “Hold” and a consensus target price of $55.00.

In other news, Chairman Steven A. Kandarian sold 85,683 shares of the business’s stock in a transaction that occurred on Tuesday, August 21st. The shares were sold at an average price of $46.93, for a total transaction of $4,021,103.19. Following the completion of the sale, the chairman now owns 585,005 shares in the company, valued at approximately $27,454,284.65. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Chairman Steven A. Kandarian sold 42,805 shares of Metlife stock in a transaction on Monday, August 27th. The shares were sold at an average price of $47.03, for a total transaction of $2,013,119.15. Following the completion of the transaction, the chairman now directly owns 559,097 shares in the company, valued at $26,294,331.91. The disclosure for this sale can be found here. 0.34% of the stock is currently owned by insiders.

Metlife stock traded up $0.07 during trading on Friday, reaching $43.83. The stock had a trading volume of 8,841,800 shares, compared to its average volume of 5,972,451. Metlife Inc has a 52-week low of $42.80 and a 52-week high of $55.91. The company has a quick ratio of 0.15, a current ratio of 0.15 and a debt-to-equity ratio of 0.29. The company has a market capitalization of $46.48 billion, a P/E ratio of 9.74, a P/E/G ratio of 0.71 and a beta of 1.23.

Metlife (NYSE:MET) last issued its quarterly earnings data on Wednesday, August 1st. The financial services provider reported $1.30 earnings per share for the quarter, topping the consensus estimate of $1.17 by $0.13. The business had revenue of $21.22 billion during the quarter, compared to the consensus estimate of $15.65 billion. Metlife had a net margin of 6.12% and a return on equity of 9.17%. The company’s revenue was up 36.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.04 EPS. As a group, research analysts anticipate that Metlife Inc will post 5.22 earnings per share for the current fiscal year.

About Metlife

MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.

Featured Article: Understanding the different types of bonds

Institutional Ownership by Quarter for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.